References
- Li S, Starkey ES. What do I need to know about glycopeptide antibiotics? Arch Dis Child Educ Pract Ed. 2016;101:323–326.
- Moise-Broder PA, Forrest A, Birmingham MC, et al. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 2004;43:925–942.
- Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2009;29:1275–1279.
- Le J, Bradley JS, Murray W, et al. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J. 2013;32:e155–e163.
- Wong G, Sime FB, Lipman J, et al. How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients? BMC Infect Dis. 2014;14:228.
- Ye ZK, Tang HL, Zhai SD. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. PloS One. 2013;8:e77169.
- Elyasi S, Khalili H. Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons. Eur J Clin Pharmacol. 2016;72:777–788.
- Sima M, Hronova K, Hartinger J, et al. A simulation of loading doses for vancomycin continuous infusion regimens in intensive care. Infect Dis. 2017;49:674–679.
- Sima M, Hartinger J, Stenglova Netikova I, et al. Creatinine clearance estimations for vancomycin maintenance dose adjustments. Am J Ther. 2018;25:e602–e604.
- Sima M, Hartinger J, Cikankova T, et al. Importance of vancomycin loading doses in intermittent infusion regimens. J Infect Chemother. 2018;24:247–250.
- da Silva Alves GC, da Silva SD, Frade VP, et al. Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis. Eur J Clin Pharmacol. 2017;73:1341–1353.
- Janssen EJ, Valitalo PA, Allegaert K, et al. Towards rational dosing algorithms for vancomycin in neonates and infants based on population pharmacokinetic modeling. Antimicrob Agents Chemother. 2016;60:1013–1021.
- Anderson BJ, Allegaert K, Van den Anker JN, et al. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol. 2007;63:75–84.
- Gerdes JS. Diagnosis and management of bacterial infections in the neonate. Pediatr Clin North Am. 2004;51:939–959.
- Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr. 1978;93:62–66.
- Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987;34:571–590.
- Martinkova J, Pokorna P, Zahora J, et al. Tolerability and outcomes of kinetically guided therapy with gentamicin in critically ill neonates during the first week of life: an open-label, prospective study. Clin Ther. 2010;32:2400–2014.
- Sima M, Pokorna P, Hartinger J, et al. Estimation of initial phenobarbital dosing in term neonates with moderate-to-severe hypoxic ischaemic encephalopathy following perinatal asphyxia. J Clin Pharm Ther. 2018;43:196–201.
- Sima M, Bakhouche H, Hartinger J, et al. Therapeutic drug monitoring of antibiotic agents: evaluation of predictive performance. Eur J Hosp Pharm. 2017. doi: 10.1136/ejhpharm-2017-001396.
- Neely MN, Youn G, Jones B, et al. Are vancomycin trough concentrations adequate for optimal dosing? Antimicrob Agents Chemother. 2014;58:309–316.
- Lestner JM, Hill LF, Heath PT, et al. Vancomycin toxicity in neonates: a review of the evidence. Curr Opin Infect Dis. 2016;29:237–247.